An asthma drug called formoterol may help reverse MASH-related liver damage, prompting new clinical trials after promising results in mice and observational human studies. Researchers at the Medical University of South Carolina are investigating new ways to treat MASH, or metabolic dysfunction-associated steatohepatitis, a serious liver disease that affects hundreds of millions of people worldwide. [...]from SciTechDaily https://ift.tt/3kauiZ4
